Suchen
Milestone Pharmaceuticals Inc
MISTZur Watchlist hinzufügen
1.320USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
155.49MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Milestone Pharmaceuticals Inc Unternehmen
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc Informationen
BörsenkürzelMIST
Name des UnternehmensMilestone Pharmaceuticals Inc
IPO-datumMay 09, 2019
CEOOliveto (Joseph)
Anzahl der mitarbeiter33
WertpapierartOrdinary Share
GeschäftsjahresendeMay 09
Addresse420-1111 boul. Dr.-Frederik-Philips
StadtMONTREAL
BörseNASDAQ OMX - NASDAQ BASIC
LandCanada
PostleitzahlH4M 2X6
Telefon15143360444
Websitehttps://www.milestonepharma.com
BörsenkürzelMIST
IPO-datumMay 09, 2019
CEOOliveto (Joseph)
Führungskräfte von Milestone Pharmaceuticals Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Mr. Jeffrey Nelson
Mr. Jeffrey Nelson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Milestone Pharmaceuticals Inc?
Die fünf größten Anteilseigner von Milestone Pharmaceuticals Inc sind: Dr. David Bharucha
Wie viele Institutionen halten Anteile an Milestone Pharmaceuticals Inc (MIST)?
Mit Stand vom 2026Q1 halten 133 Institutionen Anteile an Milestone Pharmaceuticals Inc, mit einem Gesamtmarktwert von etwa 30.89M, was 25.86% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -18702702.00 gestiegen.